HuGE Literature Finder
Records
1
-
3
WT1 Expression in Peripheral Blood at Diagnosis and During the Course of Early Consolidation Treatment Correlates With Survival in Patients With Intermediate and Poor-Risk Acute Myeloid Leukemia. Clinical lymphoma, myeloma & leukemia 2020 Aug . Šálek Cyril, Vydra Jan, Cerovská Ela, Šestáková Šárka, Ransdorfová Šárka, Válková Veronika, Cetkovský Petr, Remešová Ha |
MRD assessed by WT1 and NPM1 transcript levels identifies distinct outcomes in AML patients and is influenced by gemtuzumab ozogamicin. Oncotarget 2014 Aug 5 (15): 6280-8. Lambert Juliette, Lambert Jérôme, Nibourel Olivier, Pautas Cécile, Hayette Sandrine, Cayuela Jean-Michel, Terré Christine, Rousselot Philippe, Dombret Hervé, Chevret Sylvie, Preudhomme Claude, Castaigne Sylvie, Renneville Ali |
Core binding factor acute myeloid leukaemia and c-KIT mutations. Oncology reports 2013 May 29 (5): 1867-72. Riera Ludovica, Marmont Filippo, Toppino Daniela, Frairia Chiara, Sismondi Francesca, Audisio Ernesta, Di Bello Cristiana, D'Ardia Stefano, Di Celle Paola Francia, Messa Emanuela, Inghirami Giorgio, Vitolo Umberto, Pich Achil |
- Page last reviewed:Feb 1, 2023
- Page last updated:Feb 03, 2023
- Content source: